Chu Matsuda

10PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oral and maxillofacial surgeryMolecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 16, 2023
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer.

Chu Matsuda, Toshihiro Kudo, Yoshihiro Morimoto

|Aug 02, 2021
Investigation of the influence of pancreatic surgery on new-onset and persistent diabetes mellitus.

Daisaku Yamada, Hidenori Takahashi, Kei Asukai

|Feb 13, 2021
Crenolanib Regulates ERK and AKT/mTOR Signaling Pathways in RAS/BRAF-Mutated Colorectal Cancer Cells and Organoids.

Shiki Fujino, Norikatsu Miyoshi, Aya Ito

|Apr 02, 2020
Human NKp44+ Group 3 Innate Lymphoid Cells Associate with Tumor-Associated Tertiary Lymphoid Structures in Colorectal Cancer.

Atsuyo Ikeda, Takayuki Ogino, Hisako Kayama

|Nov 22, 2018
Cancer-associated thrombosis: Role of direct oral anticoagulants.

Masataka Ikeda, Chu Matsuda

Pageof 2